Kiniksa Pharmaceuticals International (KNSA) Stock
Kiniksa Pharmaceuticals International (KNSA) closed at $95.11 on Nov 17, 2026; its Tenet Score is 55 of 100 against 340 Healthcare peers.
11 figures withheld by our checks. Each blank figure names its reason.
Key stats
- Close
- $95.11
- Nov 17, 2026
- Market cap
- $7.4B
- share price × the latest quarter's diluted weighted-average share count (vendor)
- P/E
- 73.0×
- TTM through Sep 30, 2026 · as of close, Nov 16, 2026
- 52-week range
- 37.02 – 99.31
- low → high · as of close, Nov 16, 2026
- Tenet Score
- 55/100
- Mixed · 340 Healthcare peers
Industry: Drugs
Kiniksa Pharmaceuticals International Plc. scores 55/100. Mixed. Strongest on financial health and quality, value is the soft spot, trading at 73× earnings versus 340 Healthcare peers.
Tenet Score · vs sector
n=340Factor grades
Price
The whole report, at a glance · every card is a live peek, click any to open the section
- ~ Buffett Quality
- ~ Piotroski F-Score
- ~ Munger Compounders
- ✕ Magic Formula
- ✕ Graham Defensive
- ~ Quality Compounder
Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Its produc…
Similar-sized companies in Drugs
The 10 companies in this industry closest in market cap, as of Nov 16, 2026.
| Company | Tenet Score | Market cap |
|---|---|---|
| Protagonist Therapeutics IncPTGX | 65 | $8.1B |
| Alkermes plcALKS | 37 | $7.8B |
| Corcept Therapeutics IncCORT | 54 | $7.6B |
| Rhythm Pharmaceuticals Inc.RYTM | 36 | $7.5B |
| Cytokinetics IncCYTK | 34 | $7.4B |
| Amneal Pharmaceuticals IncAMRX | 39 | $7.4B |
| Axsome Therapeutics IncAXSM | 31 | $7.2B |
| Twist Bioscience CorpTWST | 48 | $7.2B |
| Oruka Therapeutics Inc.ORKA | 54 | $6.7B |
| Belite Bio IncBLTE | 55 | $6.4B |
Common questions
What sector and industry is Kiniksa Pharmaceuticals International in?
Kiniksa Pharmaceuticals International is in the Healthcare sector and the Drugs industry.
What is Kiniksa Pharmaceuticals International's Tenet Score?
Kiniksa Pharmaceuticals International's Tenet Score is 55 out of 100, ranked against 340 Healthcare peers as of Nov 16, 2026.




